Armata Pharmaceuticals EV 2011-2026 | ARMP

EV Jährlich Armata Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
250 M	110 M	151 M	101 M	29.7 M	1.23 K	6 M	7.29 M	25.6 M	52.3 M	95.6 M	15.9 M	14.1 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
250 M	1.23 K	66.1 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Alector ALEC	444 M	$ 2.19	-9.77 %	$ 226 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Cabaletta Bio CABA	-155 M	$ 3.34	0.45 %	$ 3.9 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Codexis CDXS	354 M	$ 1.02	1.49 %	$ 74.9 M	USA
AbCellera Biologics ABCL	1.22 B	$ 3.74	3.6 %	$ 1.12 B	Canada
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Cerus Corporation CERS	425 M	$ 2.6	1.37 %	$ 480 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
Cellectis S.A. CLLS	109 M	$ 3.87	-0.39 %	$ 116 M	France
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
CNS Pharmaceuticals CNSP	-3.42 M	$ 3.23	2.22 %	$ 1.23 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Collegium Pharmaceutical COLL	2.52 B	$ 41.75	0.19 %	$ 1.32 B	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Corcept Therapeutics Incorporated CORT	3.82 B	$ 36.14	1.23 %	$ 3.75 B	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Amarin Corporation plc AMRN	521 M	$ 13.98	1.27 %	$ 5.7 B	Irlanda
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	-64.1 M	-	4.14 %	$ 49.1 M	USA
Catalyst Pharmaceuticals CPRX	2.48 B	$ 23.77	2.99 %	$ 2.91 B	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Corbus Pharmaceuticals Holdings CRBP	66.5 M	$ 8.41	-1.87 %	$ 36.4 M	USA
Cardiff Oncology CRDF	115 M	$ 1.94	0.01 %	$ 130 M	USA
Curis CRIS	40.5 M	$ 1.1	-3.51 %	$ 6.94 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
CorMedix CRMD	142 M	$ 7.16	0.42 %	$ 364 M	USA
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Champions Oncology CSBR	125 M	$ 6.14	3.89 %	$ 83.9 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	10.8 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Citius Pharmaceuticals CTXR	63.5 M	$ 0.72	-2.34 %	$ 4.84 M	USA
Athira Pharma ATHA	-18.3 M	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	38.2 M	-	17.91 %	$ 11.1 M	USA
Altimmune ALT	442 M	$ 4.21	-2.32 %	$ 299 M	USA
CEL-SCI Corporation CVM	35.5 M	$ 3.88	-8.92 %	$ 247 M	USA